Latest Avastin news
Glaucoma Surgery Risk Up With 7+ Injections of Bevacizumab
by modernClinician Editorial Team
Seven or more injections of bevacizumab annually is associated with increased risk of glaucoma surgery, according to a study published online March 16 in JAMA Ophthalmology.
Radiomic-Based Method Predicts Recurrent Glioblastoma Outcome
by modernClinician Editorial Team
A radiomic-based approach can be used to generate a prediction model for stratifying treatment outcome among patients with recurrent glioblastoma prior to bevacizumab treatment, according to a study published online Oct. 10 in Clinical Cancer Research.
Aflibercept, Ranibizumab Not Cost-Effective Vs. Bevacizumab
by modernClinician Editorial Team
Compared with bevacizumab, aflibercept and ranibizumab are not cost-effective for diabetic macular edema, according to research published online June 9 in JAMA Ophthalmology.
Bevacizumab Use in Preemies Associated With Disabilities
by modernClinician Editorial Team
Bevacizumab (Avastin) used to treat retinopathy of prematurity may be linked to serious disabilities such as cerebral palsy and hearing loss, according to a study published online March 17 in Pediatrics.
Editor's Recommendations
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring 
Better Youth Fitness May Lower Risk for Depression in Adulthood 
Maternal Vitamin D Status Linked to Preterm Delivery 
Mom"s Poor Sleep in Late Pregnancy Linked to Offspring"s Obesity Risk in Early Childhood Related Articles
Bevacizumab, Triamcinolone Up Outcome After Cataract Surgery Monthly Specialist Briefings
Stay Connected
